title: Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation.
abstract: Information on the incidence of decompensation of chronic heart failure (CHF) in heart transplantation (HT) candidates eligible for prophylactic implantable cardioverter defibrillators (ICD) could provide insights into the influence of ICD on the timing for HT.
  
  
  METHODS
  We investigated the prevalence of candidates satisfying SCD-HeFT and MADIT-II criteria for prophylactic ICD among patients (n = 317) with CHF referred to our tertiary center for HT. In addition to standard clinical and laboratory assessments, baseline evaluation included two-dimensional standard transthoracic echocardiogram and 12-lead electrocardiogram.
  
  
  RESULTS
  At baseline, 19% of patients (n = 60) satisfied MADIT II criteria, and 58% (n = 185) fulfilled SCD-HeFT criteria. A total of 60% patients (n = 190) were eligible for prophylactic ICD implantation according to at least one set of criteria. Five-yr CHF decompensation-free survival was 68 +/- 4% in patients eligible for prophylactic ICD (p = 0.003), (RR 2.5, 95% CI 1.35-4.63).
  
  
  CONCLUSIONS
  SCD-HeFT could imply a threefold rise in ICD eligibility in tertiary settings. As ICD-eligible patients would likely remain at high risk of progressive ventricular dysfunction, strict follow-up should be considered extremely important to allow a timely referral for HT.
authors.affiliation: Cardiology Institute, University of Bologna, Bologna, Italy. francesco.grigioni@unibo.it
authors.forename: Francesco
authors.initials: F
authors.lastname: Grigioni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Boriani
authors.forename: Andrea
authors.initials: A
authors.lastname: Barbieri
authors.forename: Antonio
authors.initials: A
authors.lastname: Russo
authors.forename: Letizia
authors.initials: L
authors.lastname: Reggianini
authors.forename: Francesca
authors.initials: F
authors.lastname: Bursi
authors.forename: Luciano
authors.initials: L
authors.lastname: Potena
authors.forename: Caterina
authors.initials: C
authors.lastname: Ricci
authors.forename: Francesco
authors.initials: F
authors.lastname: Fallani
authors.forename: Fabio
authors.initials: F
authors.lastname: Coccolo
authors.forename: Gaia
authors.initials: G
authors.lastname: Magnani
authors.forename: Carlo
authors.initials: C
authors.lastname: Magelli
authors.forename: Maria G
authors.initials: MG
authors.lastname: Modena
authors.forename: Angelo
authors.initials: A
authors.lastname: Branzi
mesh_terms: D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004452:Echocardiography; D004554:Electric Countershock / Q000295:instrumentation*; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000401:mortality*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D015995:Prevalence; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors